KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShort-Term Debt issuances
Ratios

Amneal Pharmaceuticals (AMRX) Shares Issued (2018 - 2025)

Historic Shares Issued for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to $653000.0.

  • Amneal Pharmaceuticals' Shares Issued rose 583.47% to $653000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 4894.84%. This contributed to the annual value of $1.2 million for FY2024, which is 15587.58% up from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Shares Issued is $653000.0, which was up 583.47% from $685000.0 recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Shares Issued registered a high of $685000.0 during Q2 2025, and its lowest value of $5000.0 during Q2 2021.
  • Over the past 5 years, Amneal Pharmaceuticals' median Shares Issued value was $152000.0 (recorded in 2021), while the average stood at $282937.5.
  • Data for Amneal Pharmaceuticals' Shares Issued shows a peak YoY increase of 1342000.0% (in 2021) and a maximum YoY decrease of 9673.2% (in 2021) over the last 5 years.
  • Amneal Pharmaceuticals' Shares Issued (Quarter) stood at $19000.0 in 2021, then soared by 2126.32% to $423000.0 in 2022, then plummeted by 89.83% to $43000.0 in 2023, then surged by 251.16% to $151000.0 in 2024, then surged by 332.45% to $653000.0 in 2025.
  • Its last three reported values are $653000.0 in Q3 2025, $685000.0 for Q2 2025, and $69000.0 during Q1 2025.